Karyopharm Therapeutics
KPTI
#9746
Rank
A$54.33 M
Marketcap
$6.46
Share price
-2.97%
Change (1 day)
214.20%
Change (1 year)

EPS for Karyopharm Therapeutics (KPTI)

EPS in 2023 (TTM): -$1.98

According to Karyopharm Therapeutics 's latest financial reports the company's current EPS (TTM) is -$2.17. In 2022 the company made an earnings per share (EPS) of -$3.34 a decrease over its 2021 EPS that were of -$2.73.

EPS history for Karyopharm Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.98-40.68%
2022-$3.3422.29%
2021-$2.73-39.19%
2020-$4.50-15.48%
2019-$5.323.19%
2018-$5.1511.79%
2017-$4.61-4.44%
2016-$4.83-11.75%
2015-$5.4737.76%
2014-$3.97-74.5%
2013-$15.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.00-238.01%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.54-400.76%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.89-325.17%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.47-121.46%๐Ÿ‡บ๐Ÿ‡ธ USA